We are live on
!
Find out more
PCM
Piermont Capital Management Portfolio holdings
AUM
$211M
1-Year Est. Return
8.09%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
–
AUM
$327M
AUM Growth
+$27M
(+9%)
Cap. Flow
+$13.4M
Cap. Flow
% of AUM
4.11%
Top 10 Holdings %
Top 10 Hldgs %
10.9%
Holding
283
New
46
Increased
97
Reduced
61
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AAN.A
The Aaron's Company Inc Class A
AAN.A
|
+$3.01M |
| 2 |
Sabra Healthcare REIT
SBRA
|
+$2.69M |
| 3 |
SouthState Bank Corp
SSB
|
+$2.66M |
| 4 |
Walker & Dunlop
WD
|
+$2.65M |
| 5 |
Vishay Intertechnology
VSH
|
+$2.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Green Dot
GDOT
|
+$4.11M |
| 2 |
Wolfspeed
WOLF
|
+$3.27M |
| 3 |
Brunswick
BC
|
+$3.16M |
| 4 |
UCB
United Community Banks
UCB
|
+$3.13M |
| 5 |
Louisiana-Pacific
LPX
|
+$2.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.23% |
| 2 | Industrials | 16.56% |
| 3 | Real Estate | 13.09% |
| 4 | Technology | 10.37% |
| 5 | Consumer Discretionary | 10.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTRI
226
DELISTED
NutriSystem, Inc.
NTRI
| $223K | 0.07% |
+5,800
| New | +$192K |
|
227
Pitney Bowes
PBI
$2.39B
| $221K | 0.07% |
25,770
-4,150
| -14% | -$40.1K |
|
228
Phibro Animal Health
PAHC
$1.39B
| $220K | 0.07% |
4,770
-840
| -15% | -$37.2K |
|
|
GHDX
229
DELISTED
Genomic Health, Inc.
GHDX
| $211K | 0.06% |
+4,190
| New | +$166K |
|
230
Vanda Pharmaceuticals
VNDA
$302M
| $206K | 0.06% |
10,820
-1,910
| -15% | -$31.9K |
|
231
Lantheus
LNTH
$6.59B
| $195K | 0.06% |
13,380
-2,640
| -16% | -$40.6K |
|
|
CALA
232
DELISTED
Calithera Biosciences, Inc
CALA
| $192K | 0.06% |
+1,920
| New | +$218K |
|
|
PVLA
233
Palvella Therapeutics
PVLA
$2.27B
| $178K | 0.05% |
+439
| New | +$209K |
|
234
Inovio Pharmaceuticals
INO
$69M
| $89K | 0.03% |
1,894
-359
| -16% | -$19.8K |
|
235
Applied Industrial Technologies
AIT
$13.3B
| – | – |
-9,050
| Closed | -$660K |
|
236
Akebia Therapeutics
AKBA
$252M
| – | – |
-10,830
| Closed | -$103K |
|
237
Amphastar Pharmaceuticals
AMPH
$916M
| – | – |
-10,870
| Closed | -$204K |
|
|
AVNS
238
DELISTED
Avanos Medical
AVNS
| – | – |
-50,770
| Closed | -$2.34M |
|
|
239
Brunswick
BC
$5.28B
| – | – |
-53,170
| Closed | -$3.16M |
|
240
Beazer Homes USA
BZH
$907M
| – | – |
-129,070
| Closed | -$2.06M |
|
241
Cabot Corp
CBT
$4.52B
| – | – |
-43,894
| Closed | -$2.45M |
|
242
Customers Bancorp
CUBI
$2.77B
| – | – |
-55,960
| Closed | -$1.63M |
|
243
Commault Systems
CVLT
$5.61B
| – | – |
-9,010
| Closed | -$515K |
|
244
Cytokinetics
CYTK
$10.4B
| – | – |
-16,530
| Closed | -$119K |
|
245
Essent Group
ESNT
$6.33B
| – | – |
-17,330
| Closed | -$738K |
|
246
Evercore
EVR
$11.8B
| – | – |
-5,020
| Closed | -$438K |
|
|
KYNB
247
Kyntra Bio
KYNB
$29.4M
| – | – |
-200
| Closed | -$231K |
|
248
Flowers Foods
FLO
$1.57B
| – | – |
-108,480
| Closed | -$2.37M |
|
249
Fulton Financial
FULT
$4.64B
| – | – |
-129,790
| Closed | -$2.3M |
|
|
250
Green Dot
GDOT
$745M
| – | – |
-64,019
| Closed | -$4.11M |
|
Similar funds
WAM
GIM
PPC
MA
PC
HCG
WA
VAM
Piermont Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Piermont Capital Management held 283 positions worth $327M, up 9% from $300M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Piermont Capital Management deployed $13.4M of net new capital in Q2 2018, opening 46 new positions and adding to 97 existing holdings. Its largest new stake was The Aaron's Company Inc Class A: 69,190 shares worth $3.01M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 24% a quarter earlier, followed by Industrials and Real Estate.
On the sell side, the largest reduction was Louisiana-Pacific, an estimated $2.8M trimmed.
- Piermont Capital Management's largest Q2 2018 buy was The Aaron's Company Inc Class A: 69,190 shares worth $3.01M.
- Piermont Capital Management added most to Stepan Co in Q2 2018, an estimated $2.48M increase.
- Piermont Capital Management's biggest Q2 2018 reduction was Louisiana-Pacific, cutting an estimated $2.8M.
- Piermont Capital Management fully exited Green Dot in Q2 2018, selling an estimated $4.11M.
- Piermont Capital Management's ten largest holdings make up 11% of its $327M portfolio in Q2 2018.
- Piermont Capital Management opened 46 new positions and closed 49 in Q2 2018.
- Piermont Capital Management's portfolio value rose 9% quarter-over-quarter to $327M.
Based on Piermont Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.